Back to directory
Country
United States
City
Philadelphia
Founded
—
Headcount
11-50
Pennsylvania
Description
FORE Biotherapeutics raises $67.4M to support development of plixorafenib, a targeted cancer therapy.
Funding history
-
Unknown
Lead SR One
Investors SR One, Medicxi, SymBiosis, TaiAx, LG Technology Ventures, Primer Ventures
FORE Biotherapeutics raises $67.4M to support development of plixorafenib, a targeted cancer therapy.
—
Source
Founders
-
Shawn Leland
Co-Founder